TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Salipro Biotech AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,046
|
7,064
|
4,397 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
-4,320
|
-2,276
|
-1,893 |
EBITDA |
-3,757
|
-1,747
|
-1,427 |
Total assets |
15,824
|
18,564
|
21,423 |
Current assets |
9,669
|
13,498
|
16,637 |
Current liabilities |
1,756
|
1,394
|
1,375 |
Equity capital |
14,068
|
17,169
|
20,048 |
- share capital |
70
|
65
|
67 |
Employees (average) |
9
|
7
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
88.9%
|
92.5%
|
93.6% |
Turnover per employee |
672
|
1,009
|
733 |
Profit as a percentage of turnover |
-71.5%
|
-32.2%
|
-43.1% |
Return on assets (ROA) |
-27.3%
|
-12.3%
|
-8.8% |
Current ratio |
550.6%
|
968.3%
|
1210.0% |
Return on equity (ROE) |
-30.7%
|
-13.3%
|
-9.4% |
Change turnover |
-1,520
|
2,799
|
950 |
Change turnover % |
-20%
|
66%
|
28% |
Chg. No. of employees |
2
|
1
|
0 |
Chg. No. of employees % |
29%
|
17%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.